Show simple item record

2012-06-26Heft oder Ausgabe einer Zeitschrift DOI: 10.25646/3043
Pharmacological Neuroenhancement
dc.contributor.authorSchilling, Ralph
dc.contributor.authorHoebel, Jens
dc.contributor.authorMüters, Stephan
dc.contributor.authorLange, Cornelia
dc.date.accessioned2018-05-07T21:30:04Z
dc.date.available2018-05-07T21:30:04Z
dc.date.created2014-02-13
dc.date.issued2012-06-26none
dc.identifier.otherhttp://edoc.rki.de/series/gbe-kompakt/3-3/PDF/3_de.pdf
dc.identifier.urihttp://edoc.rki.de/176904/3118
dc.description.abstractJune, 26th is International Day against Drug Abuse and Illicit Trafficking. Neuroenhancement is therefore the focus of this issue of GBE kompakt. Results of KOLIBRI, a study by Robert Koch-Institute, are presented which show who is doing cognitive enhancement and why. The results are discussed in context of other studies, but show similar outcomes.eng
dc.language.isoger
dc.publisherRobert Koch-Institut
dc.subjectGEDAeng
dc.subjectprevalenceeng
dc.subjectNeuroenhancementeng
dc.subjectdopingeng
dc.subjectKOLIBRIeng
dc.subject.ddc610 Medizin
dc.titlePharmacological Neuroenhancement
dc.typePeriodicalPart
dc.identifier.urnurn:nbn:de:0257-10038663
dc.identifier.doihttp://dx.doi.org/10.25646/3043
local.edoc.container-titleGBE kompakt
local.edoc.container-titleGBE kompakt
local.edoc.pages7
local.edoc.type-nameHeft oder Ausgabe einer Zeitschrift
local.edoc.container-volume3
local.edoc.container-issue3
local.edoc.container-year2012

Show simple item record